Frontlight ResearchEarly access
Trial site
Consultants in Epilepsy and Neurology PLLC
- 4running trials
- 3closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Epilepsy7 trials
- Phase
- Phase 34 trials
- Phase 23 trials
- Status
- Completed3 trials
- Recruiting3 trials
- Active, not recruiting1 trial
- Lead sponsor
- Xenon Pharmaceuticals Inc.3 trials
- Rapport Therapeutics Inc.2 trials
- SK Life Science, Inc.2 trials
Running trials
Recruiting
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
Recruiting
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Active, not recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Epilepsy3 recruiting
Closed trials
Completed
Recruiting
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026